The EVERDAC Trial: Non-Invasive BP vs Arterial Lines in the Critically Ill
The EVERDAC trial sought to determine if managing shock with noninvasive brachial cuff monitoring is noninferior to early (<4 hours) arterial catheter placement
The EVERDAC trial sought to determine if managing shock with noninvasive brachial cuff monitoring is noninferior to early (<4 hours) arterial catheter placement
POCUS diastology doesn’t diagnose chronic diastolic dysfunction—it estimates left atrial pressure in real time. Learn how to capture E and e’ from an apical 4-chamber view, calculate E/e’, and rapidly distinguish cardiogenic pulmonary edema from other causes of acute dyspnea ...
Prior research has shown that deep tracheal suctioning can result in more rapid development of hypoxemia. It is unclear if continuous suctioning during intubation poses a similar risk. Does the application of continuous suctioning during rapid sequence intubation (RSI) result ...
The RENOVATE trial set out to answer a high-impact question across five distinct etiologic groups: Is HFNC non-inferior to BPAP (NIV) for preventing intubation or death in acute respiratory failure?
Host Dr. Mark Ramzy shines a spotlight on two phenomenal educators: Drs. Sara Crager and Ryan Ernst who shared their expertise and experiences at this transformative gathering last spring.
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.